The combination of an immunotherapy with a targeted antiangiogenic therapy offers patients a novel treatment option

Piqray in combination with fulvestrant is the first treatment for tumours with a PIK3CA mutation

The trial will enrol patients with mild symptoms of SARS-CoV-2 infection to evaluate the safety, tolerability, efficacy, pharmacokinetics […]

The patch will be tested to deliver a vaccine dose via the skin, as well as achieve a […]

The new approval cover paediatric patients with plaque psoriasis

To determine immunity to Sars-Cov-2 and the effectiveness of potential vaccines, the amount of neutralising antibodies in the […]

Biofilms, microscopic entities not visible by the naked eye, go undetected by health professionals damaging healing tissue and […]

Roche’s Tecentriq triplet nabs melanoma OK, but BMS’ Opdivo-Yervoy still reigns supreme chelfand Fri, 07/31/2020 – 01:54

Updated Date: Thu, 23 Jul 2020 00:00:00 EDT

Updated Date: Thu, 23 Jul 2020 00:00:00 EDT